Developer docs
API playgroundTry for free, no card

Search company profiles

Roka Bioscience

Full company profile

uuid0006duu

Namestring
Roka Bioscience
Legal namestring
Roka Bioscience, Inc.
Websiteurl
rokabio.com
Company typeenum
Public
Founded yearint
2009
Descriptiontext

Roka Bioscience is a US-based molecular diagnostics company that develops and commercializes automated pathogen detection assays and instrument systems for the food safety industry. Founded in 2009 as a spin-off of Gen-Probe's (now Hologic) industrial testing assets, the company holds an exclusive license to rRNA-targeting technology and combines three core methods — Target Capture, Transcription-Mediated Amplification, and Hybridization Protection Assay — into a single closed workflow run on its proprietary Atlas System instrument. The assay menu covers the pathogens most relevant to food industry compliance: Listeria species and L. monocytogenes, Salmonella, E. coli O157:H7 and STEC, Campylobacter, and Legionella (the last extending into water testing), and the majority of these assays carry AOAC Research Institute Performance Tested Method certifications.

The company operates a razor-and-blade business model, generating revenue from sales of the Atlas System instrument and from recurring consumables (assay kits in 225–250 test kit sizes, plus calibrators and control materials), with most products sold direct to food manufacturers and third-party testing laboratories via a sales-led motion (toll-free phone, email-based ordering, and 24/7/365 technical support). Roka segments its commercial effort across eight food industry verticals — beef, dairy, pet food, poultry, produce, ready-to-eat foods, spices and ingredients, and environmental testing — addressing pain points such as false positives in difficult matrices (e.g., Salmonella/Citrobacter cross-reactivity in pet food), faster product release, and reduced enrichment times relative to traditional immunoassay and PCR-based methods. The company was previously publicly traded on NASDAQ under ticker ROKA but is now delisted; current headcount is 51–100 employees.

Short descriptiontext

Roka Bioscience is a US-based molecular diagnostics company that sells the Atlas System, an automated instrument plus assay kits for detecting foodborne pathogens such as Listeria, Salmonella, and E. coli, to food manufacturers and third-party testing laboratories.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWarren, United States
HQ citystring
Warren
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular pathogen detection, food safety testing, pathogen detection assays, molecular diagnostics instruments, foodborne illness testing
Industry3 codes
1Food Testing Laboratories (Microbiological, Chemical, Allergen)
CodeAFALAAAAPrimaryYes
2Environmental Pathogen Monitoring Programs (Listeria, Salmonella, STEC)
CodeAFALAEAAPrimaryNo
3Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring)
CodeAFALAAAEPrimaryNo
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Testing Laboratories8734
  • Laboratory Analytical Instruments3826
Product category
Food Safety Testing (Molecular Pathogen Detection)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Atlas System Instrument Sales
TypeHardware Sales
Description

Sale of the Atlas System, a fully automated molecular pathogen detection instrument for food safety testing.

rokabio.com
2Detection Assay Kits and Consumables
TypeHardware Sales
Description

Sale of pathogen detection assay kits including Listeria, Salmonella, E. coli O157:H7, STEC, Campylobacter, and Legionella assays. Kits come in various sizes (225-250 tests per kit) with catalog numbers for ordering.

rokabio.com
3Calibrators and Control Materials
TypeHardware Sales
Description

Sale of calibrators for assay validation and quality control, such as Atlas Listeria monocytogenes LmG2 Calibrators.

rokabio.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Detection assay kits available by catalog
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Assays available in kit sizes: 225 tests per kit (LmG2), 250 tests per kit (most others). Catalog numbers provided for ordering.

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Roka Bioscience develops and sells the Atlas® System, a fully automated molecular pathogen detection instrument, paired with a portfolio of ribosomal RNA-targeting detection assays for Listeria, Salmonella, E. coli O157:H7, STEC, Campylobacter, and Legionella. The company supplies assay kits (225–250 tests per kit), calibrators, and consumables to food manufacturers and third-party food safety testing laboratories across multiple food verticals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced enrichment times compared to traditional methods
+2 more records
Product overview1 text field

Roka Bioscience offers a platform-plus-modules architecture centered on the Atlas® System, a fully automated molecular pathogen detection instrument. The core platform runs a portfolio of specialized detection assays that target ribosomal RNA (rRNA) for food safety testing. The assay portfolio includes: the Atlas E. coli O157:H7 EG2 Detection Assay, Atlas STEC EG2 Combo Detection Assay, Atlas Listeria LSP Detection Assay, Atlas Listeria Environmental LE Detection Assay, Atlas Listeria monocytogenes LmG2 Detection Assay, Atlas Salmonella SEN Detection Assay, Atlas Campylobacter CAMPY Detection Assay, and Atlas Legionella LGN Detection Assay. The system combines three core molecular technologies—Target Capture (automated sample purification), Transcription-Mediated Amplification (isothermal nucleic acid amplification), and Hybridization Protection Assay (chemiluminescent detection)—to deliver fully automated, single-protocol pathogen testing with reduced enrichment times and superior sensitivity.

Product and service10 records
1Atlas® System
CategoryFood safety testing instruments
Description

A fully automated molecular pathogen detection instrument dedicated to the food safety industry. The Atlas® System enhances accuracy, speed, and efficiency of food safety testing by detecting Listeria, Salmonella, Escherichia coli, and other food-contamination organisms using Target Capture, TMA, and HPA technology, requiring only one operator and providing walk-away automation.

2Atlas E. coli O157:H7 EG2 Detection Assay
CategoryPathogen detection assay kits
Description

A molecular detection assay kit for Escherichia coli O157:H7 in beef and produce samples, the first AOAC-approved assay of its kind (PTM #011401). Detects the E. coli strain most commonly associated with foodborne illness.

3Atlas STEC EG2 Combo Detection Assay
CategoryPathogen detection assay kits
Description

A rapid, accurate, and reliable molecular test for STEC (Shiga toxin-producing E. coli) detection from a variety of food samples, targeting both E. coli O157:H7 and non-O157 STECs in a single assay.

4Atlas Listeria LSP Detection Assay
CategoryPathogen detection assay kits
Description

A rapid, highly accurate molecular assay designed for food and environmental samples, detecting Listeria genus bacteria that can cause listeriosis (PTM #011201).

5Atlas Listeria Environmental LE Detection Assay
CategoryPathogen detection assay kits
Description

A rapid, accurate, and reliable molecular assay specifically designed for the unique challenges of environmental samples, detecting Listeria species in processing plant conditions (PTM #061503).

6Atlas Listeria monocytogenes LmG2 Detection Assay
CategoryPathogen detection assay kits
Description

A rapid, accurate, and reliable molecular test for detection of Listeria monocytogenes, the pathogen that causes listeriosis and is widely prevalent in the environment (PTM #111301; 225 tests/kit).

7Atlas Salmonella SEN Detection Assay
CategoryPathogen detection assay kits
Description

A rapid and highly accurate molecular assay for detecting Salmonella bacteria in food and environmental samples, targeting the pathogen responsible for more foodborne hospitalizations than any other (PTM #031201).

8Atlas Campylobacter CAMPY Detection Assay
CategoryPathogen detection assay kits
Description

A rapid, accurate molecular method for detecting Campylobacter jejuni, C. coli, and C. lari in chicken carcass rinse, turkey carcass sponge, raw ground poultry, raw ground pork, and ready-to-eat meats (PTM #032101).

9Atlas Legionella LGN Detection Assay
CategoryPathogen detection assay kits
Description

A rapid, accurate molecular method for detecting Legionella pneumophila and Legionella longbeachae in potable and non-potable water samples with or without enrichment. Validated as equivalent to or better than ISO 11731 (2017) reference method.

10Atlas Listeria monocytogenes LmG2 Calibrators
CategoryCalibrators and control materials
Description

Calibrators for the Atlas Listeria monocytogenes LmG2 Detection Assay, used for assay validation and quality control.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

MilliporeSigma sells microbiology testing products and molecular reagents used in food pathogen detection workflows, serving overlapping food safety customers through its broad life science distribution network.

TypeEmerging player
Description

QIAGEN's food safety molecular testing portfolio (e.g., mericon pathogen detection kits) provides PCR-based food pathogen testing with global distribution, representing an adjacent technology approach competing with Roka's isothermal TMA-based platform.

TypeDirect peer
Description

Bio-Rad's Life Science segment sells molecular detection systems and immunoassays for foodborne pathogen testing (e.g., iQ-Check PCR kits for Salmonella, Listeria, E. coli O157:H7), directly competing with Roka's Atlas assays in the same food manufacturer and third-party lab customer base.

TypeBroad incumbent
Description

Eurofins operates a global food testing services network (including GeneScan pathogen testing), making it both a potential customer of Roka's technology and a large incumbent offering in-house testing services that compete with end-customers' choice of in-house Roka systems.

TypeBroad incumbent
Description

bioMérieux's Industrial Microbiology division (including BioBall, GENE-UP PCR assays for Salmonella, Listeria, E. coli) provides food pathogen detection solutions, overlapping significantly with Roka's target customer verticals and assay portfolio.

TypeDirect peer
Description

3M Food Safety sells molecular detection assays (e.g., 3M Molecular Detection Assay for Salmonella, Listeria, E. coli O157:H7) targeting the same food manufacturer customer base as Roka, with established global distribution and brand recognition.

TypeDirect peer
Description

Hygiena offers molecular food pathogen testing (e.g., BAX System, SureTrend) plus ATP hygiene monitoring, directly competing with Roka's Atlas assays and serving the same food safety testing labs and food manufacturers.

TypeDirect peer
Description

Neogen provides molecular food safety testing (e.g., NeoSeek, ANSR pathogen detection systems) plus a broad range of food safety diagnostics, competing directly with Roka in the food manufacturer pathogen testing market.

TypeBroad incumbent
Description

Thermo Fisher offers molecular food pathogen testing solutions (including the Oxoid and Remel product lines and the Applied Biosystems QuantStudio platform) across a broad life sciences portfolio, making it a large incumbent competitor in food safety molecular testing.

TypeEmerging player
Description

BioFire's FilmArray molecular panels extend bioMérieux's reach into rapid pathogen testing; while primarily clinical, the platform's molecular technology and workflow principles parallel the automated, walk-away food safety testing approach Roka pursues with Atlas.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile10 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Roka Bioscience

Food Safety Testing (Molecular Pathogen Detection)rokabio.com

Roka Bioscience is a US-based molecular diagnostics company that sells the Atlas System, an automated instrument plus assay kits for detecting foodborne pathogens such as Listeria, Salmonella, and E. coli, to food manufacturers and third-party testing laboratories.

What Roka Bioscience does

Roka Bioscience is a US-based molecular diagnostics company that develops and commercializes automated pathogen detection assays and instrument systems for the food safety industry. Founded in 2009 as a spin-off of Gen-Probe's (now Hologic) industrial testing assets, the company holds an exclusive license to rRNA-targeting technology and combines three core methods — Target Capture, Transcription-Mediated Amplification, and Hybridization Protection Assay — into a single closed workflow run on its proprietary Atlas System instrument. The assay menu covers the pathogens most relevant to food industry compliance: Listeria species and L. monocytogenes, Salmonella, E. coli O157:H7 and STEC, Campylobacter, and Legionella (the last extending into water testing), and the majority of these assays carry AOAC Research Institute Performance Tested Method certifications.

The company operates a razor-and-blade business model, generating revenue from sales of the Atlas System instrument and from recurring consumables (assay kits in 225–250 test kit sizes, plus calibrators and control materials), with most products sold direct to food manufacturers and third-party testing laboratories via a sales-led motion (toll-free phone, email-based ordering, and 24/7/365 technical support). Roka segments its commercial effort across eight food industry verticals — beef, dairy, pet food, poultry, produce, ready-to-eat foods, spices and ingredients, and environmental testing — addressing pain points such as false positives in difficult matrices (e.g., Salmonella/Citrobacter cross-reactivity in pet food), faster product release, and reduced enrichment times relative to traditional immunoassay and PCR-based methods. The company was previously publicly traded on NASDAQ under ticker ROKA but is now delisted; current headcount is 51–100 employees.

Roka Bioscience firmographics

Firmographics
Name
Roka Bioscience
Legal name
Roka Bioscience, Inc.
Website
https://rokabio.com
Company type
Public
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Roka Bioscience is a US-based molecular diagnostics company that sells the Atlas System, an automated instrument plus assay kits for detecting foodborne pathogens such as Listeria, Salmonella, and E. coli, to food manufacturers and third-party testing laboratories.
Ownership category
akta.pro rank

Roka Bioscience industry classification

Industry
Product category
Food Safety Testing (Molecular Pathogen Detection)
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Testing Laboratories (8734), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA)
akta.pro secondary industries
Environmental Pathogen Monitoring Programs (Listeria, Salmonella, STEC) (AFALAEAA), Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring) (AFALAAAE)

Keywords

  • Molecular pathogen detection
  • Food safety testing
  • Pathogen detection assays
  • Molecular diagnostics instruments
  • Foodborne illness testing

Where Roka Bioscience is headquartered

Location

Headquarters

HQ city
Warren
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Roka Bioscience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Atlas System Instrument Sales: Sale of the Atlas System, a fully automated molecular pathogen detection instrument for food safety testing.
  2. Detection Assay Kits and Consumables: Sale of pathogen detection assay kits including Listeria, Salmonella, E. coli O157:H7, STEC, Campylobacter, and Legionella assays. Kits come in various sizes (225-250 tests per kit) with catalog numbers for ordering.
  3. Calibrators and Control Materials: Sale of calibrators for assay validation and quality control, such as Atlas Listeria monocytogenes LmG2 Calibrators.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goDetection assay kits available by catalog

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Roka Bioscience product offering

Product offering

Core offering

Roka Bioscience develops and sells the Atlas® System, a fully automated molecular pathogen detection instrument, paired with a portfolio of ribosomal RNA-targeting detection assays for Listeria, Salmonella, E. coli O157:H7, STEC, Campylobacter, and Legionella. The company supplies assay kits (225–250 tests per kit), calibrators, and consumables to food manufacturers and third-party food safety testing laboratories across multiple food verticals.

Product overview

Roka Bioscience offers a platform-plus-modules architecture centered on the Atlas® System, a fully automated molecular pathogen detection instrument. The core platform runs a portfolio of specialized detection assays that target ribosomal RNA (rRNA) for food safety testing. The assay portfolio includes: the Atlas E. coli O157:H7 EG2 Detection Assay, Atlas STEC EG2 Combo Detection Assay, Atlas Listeria LSP Detection Assay, Atlas Listeria Environmental LE Detection Assay, Atlas Listeria monocytogenes LmG2 Detection Assay, Atlas Salmonella SEN Detection Assay, Atlas Campylobacter CAMPY Detection Assay, and Atlas Legionella LGN Detection Assay. The system combines three core molecular technologies—Target Capture (automated sample purification), Transcription-Mediated Amplification (isothermal nucleic acid amplification), and Hybridization Protection Assay (chemiluminescent detection)—to deliver fully automated, single-protocol pathogen testing with reduced enrichment times and superior sensitivity.

Differentiator

Problem solved

Functional benefit

Products and services

  • Atlas® System A fully automated molecular pathogen detection instrument dedicated to the food safety industry. The Atlas® System enhances accuracy, speed, and efficiency of food safety testing by detecting Listeria, Salmonella, Escherichia coli, and other food-contamination organisms using Target Capture, TMA, and HPA technology, requiring only one operator and providing walk-away automation.
  • Atlas E. coli O157:H7 EG2 Detection Assay A molecular detection assay kit for Escherichia coli O157:H7 in beef and produce samples, the first AOAC-approved assay of its kind (PTM #011401). Detects the E. coli strain most commonly associated with foodborne illness.
  • Atlas STEC EG2 Combo Detection Assay A rapid, accurate, and reliable molecular test for STEC (Shiga toxin-producing E. coli) detection from a variety of food samples, targeting both E. coli O157:H7 and non-O157 STECs in a single assay.
  • Atlas Listeria LSP Detection Assay A rapid, highly accurate molecular assay designed for food and environmental samples, detecting Listeria genus bacteria that can cause listeriosis (PTM #011201).
  • Atlas Listeria Environmental LE Detection Assay A rapid, accurate, and reliable molecular assay specifically designed for the unique challenges of environmental samples, detecting Listeria species in processing plant conditions (PTM #061503).
  • Atlas Listeria monocytogenes LmG2 Detection Assay A rapid, accurate, and reliable molecular test for detection of Listeria monocytogenes, the pathogen that causes listeriosis and is widely prevalent in the environment (PTM #111301; 225 tests/kit).
  • Atlas Salmonella SEN Detection Assay A rapid and highly accurate molecular assay for detecting Salmonella bacteria in food and environmental samples, targeting the pathogen responsible for more foodborne hospitalizations than any other (PTM #031201).
  • Atlas Campylobacter CAMPY Detection Assay A rapid, accurate molecular method for detecting Campylobacter jejuni, C. coli, and C. lari in chicken carcass rinse, turkey carcass sponge, raw ground poultry, raw ground pork, and ready-to-eat meats (PTM #032101).
  • Atlas Legionella LGN Detection Assay A rapid, accurate molecular method for detecting Legionella pneumophila and Legionella longbeachae in potable and non-potable water samples with or without enrichment. Validated as equivalent to or better than ISO 11731 (2017) reference method.
  • Atlas Listeria monocytogenes LmG2 Calibrators Calibrators for the Atlas Listeria monocytogenes LmG2 Detection Assay, used for assay validation and quality control.

Quantifiable outcome

  • Reduced enrichment times compared to traditional methods
  • +2 more outcomes

Companies that use Roka Bioscience

Customer profile

Named customers2 records

Segments8 records

Ideal customer profiles10 records

Roka Bioscience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Roka Bioscience partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves7 records

Expansion highlights3 records

Roka Bioscience competitors and assessment

Company assessment

Broad incumbents

  • MilliporeSigma (Merck KGaA Life Science): MilliporeSigma sells microbiology testing products and molecular reagents used in food pathogen detection workflows, serving overlapping food safety customers through its broad life science distribution network.
  • Eurofins Scientific: Eurofins operates a global food testing services network (including GeneScan pathogen testing), making it both a potential customer of Roka's technology and a large incumbent offering in-house testing services that compete with end-customers' choice of in-house Roka systems.
  • bioMérieux: bioMérieux's Industrial Microbiology division (including BioBall, GENE-UP PCR assays for Salmonella, Listeria, E. coli) provides food pathogen detection solutions, overlapping significantly with Roka's target customer verticals and assay portfolio.
  • Thermo Fisher Scientific: Thermo Fisher offers molecular food pathogen testing solutions (including the Oxoid and Remel product lines and the Applied Biosystems QuantStudio platform) across a broad life sciences portfolio, making it a large incumbent competitor in food safety molecular testing.

Emerging players

  • QIAGEN: QIAGEN's food safety molecular testing portfolio (e.g., mericon pathogen detection kits) provides PCR-based food pathogen testing with global distribution, representing an adjacent technology approach competing with Roka's isothermal TMA-based platform.
  • bioMérieux (GENE-UP) / Roka Genomic Comparator: BioFire (bioMérieux): BioFire's FilmArray molecular panels extend bioMérieux's reach into rapid pathogen testing; while primarily clinical, the platform's molecular technology and workflow principles parallel the automated, walk-away food safety testing approach Roka pursues with Atlas.

Direct peers

  • Bio-Rad Laboratories: Bio-Rad's Life Science segment sells molecular detection systems and immunoassays for foodborne pathogen testing (e.g., iQ-Check PCR kits for Salmonella, Listeria, E. coli O157:H7), directly competing with Roka's Atlas assays in the same food manufacturer and third-party lab customer base.
  • 3M Food Safety: 3M Food Safety sells molecular detection assays (e.g., 3M Molecular Detection Assay for Salmonella, Listeria, E. coli O157:H7) targeting the same food manufacturer customer base as Roka, with established global distribution and brand recognition.
  • Hygiena: Hygiena offers molecular food pathogen testing (e.g., BAX System, SureTrend) plus ATP hygiene monitoring, directly competing with Roka's Atlas assays and serving the same food safety testing labs and food manufacturers.
  • Neogen Corporation: Neogen provides molecular food safety testing (e.g., NeoSeek, ANSR pathogen detection systems) plus a broad range of food safety diagnostics, competing directly with Roka in the food manufacturer pathogen testing market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Roka Bioscience social profiles

Digital presence

Roka Bioscience compliance and trust

Trust signal

Compliance6 records

Roka Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Roka Bioscience leadership team

Management profile

Number of profiles

Profiles3 records

Roka Bioscience funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Roka Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roka Bioscience

What does Roka Bioscience do?

Roka Bioscience develops and sells the Atlas® System, a fully automated molecular pathogen detection instrument, paired with a portfolio of ribosomal RNA-targeting detection assays for Listeria, Salmonella, E. coli O157:H7, STEC, Campylobacter, and Legionella. The company supplies assay kits (225–250 tests per kit), calibrators, and consumables to food manufacturers and third-party food safety testing laboratories across multiple food verticals.

Is Roka Bioscience a public or private company?

Roka Bioscience is a public company. It is classified as venture growth investor backed and is currently operating.

When was Roka Bioscience founded?

Roka Bioscience was founded in 2009. It employs 51 to 100 people.

Where is Roka Bioscience based?

Roka Bioscience is headquartered in Warren, United States, in the North America region.

How does Roka Bioscience make money?

Three revenue lines are on record. Atlas System Instrument Sales are the primary driver. The others are detection Assay Kits and Consumables and calibrators and Control Materials.

Who are Roka Bioscience's main competitors?

Broad incumbents on record are MilliporeSigma (Merck KGaA Life Science), Eurofins Scientific, bioMérieux and Thermo Fisher Scientific. Emerging players are QIAGEN and bioMérieux (GENE-UP) / Roka Genomic Comparator: BioFire (bioMérieux). Direct peers are Bio-Rad Laboratories, 3M Food Safety, Hygiena and Neogen Corporation.

Does Roka Bioscience have an API?

No public API is recorded for Roka Bioscience.

What industry is Roka Bioscience in?

Roka Bioscience's product category is Food Safety Testing (Molecular Pathogen Detection). Its primary akta.pro industry code is AFALAAAA, Food Testing Laboratories (Microbiological, Chemical, Allergen), with a secondary code of AFALAEAA, Environmental Pathogen Monitoring Programs (Listeria, Salmonella, STEC). Its NAICS code is 334516 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireRoka Bioscience Announces AOAC Certification for 18-hour Sample Enrichment using ActeroTM ELITE Listeria Enrichment Media and the Atlas® Listeria Environmental AssayRoka Bioscience has received AOAC Performance Tested Methods certification from the AOAC Research Institute for its Atlas Listeria Environmental Detection Assay when used with FoodChek Systems' Actero ELITE Listeria Enrichment Media, enabling 18 to 24-hour Listeria spp. enrichment testing for environmental samples. Independent laboratory validation was conducted by Q Laboratories as part of the AOAC-RI third-party evaluation process. The certification provides food processors with faster environmental Listeria detection capability amid increasing FDA regulation and food safety scrutiny.PR NewswireRoka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE BioscienceRoka Bioscience, Inc. announced a two-year nonexclusive supply agreement with PURE Bioscience to market PURE's antimicrobial disinfecting and sanitizing processing aids to the food industry. The partnership expands Roka Bioscience's reach into food production operational environments with environmental and surface disinfectants, complementing its Atlas system for foodborne pathogen testing. PURE Bioscience stated the partnership will enable it to extend its silver dihydrogen citrate based antimicrobial solutions to Roka's customer portfolio.PR NewswireRoka Bioscience to Present at the International Association of Food Protection ConferenceRoka Bioscience, a molecular diagnostics company focused on food safety testing, announced its participation and presentation at the 2017 International Association for Food Protection Conference held in Tampa, Florida from July 9-12. Dr. Evan Chaney, Director of Microbiology and Customer Applications, will present data on molecular detection methods, and the company will showcase four posters during the event. Roka Bioscience is also sponsoring the Harold Barnum Award, which recognizes outstanding service to the public, with Michael Roberson of Publix Super Markets named as the 2017 recipient.PR NewswireRoka Bioscience Reports First Quarter 2017 Financial ResultsRoka Bioscience reported Q1 2017 revenue of $2.0 million, a 26% increase year-over-year driven by higher pathogen detection test sales, with 54 Atlas instruments placed with commercial customers as of March 31, 2017. The company posted a net loss of $7.6 million ($1.53 per share), improved from an $8.2 million loss in Q1 2016, while cash and marketable securities declined to $16.2 million from $24.8 million at year-end 2016.PR NewswireRoka Bioscience, Inc. Announces Distribution Partnership with FoodChek Systems Inc.Roka Bioscience, Inc. announced on May 8, 2017 that it has entered into a 5-year non-exclusive distribution agreement with FoodChek Systems Inc. to distribute FoodChek's Actero™ ELITE and UNIVERSAL Enrichment Media products for food safety pathogen testing. The partnership expands Roka's product menu for food safety laboratories by combining FoodChek's enrichment media with Roka's Atlas® detection system, which the companies say will improve testing accuracy, reduce time-to-result, and enhance workflow efficiency for end users.PR NewswireRoka Bioscience to Present and Exhibit at the 2017 Food Safety SummitRoka Bioscience, Inc. announced it will present and exhibit at the 2017 Food Safety Summit held at the Donald Stevens Convention Center in Rosemont, Illinois from May 8-11. Dr. Erin Dreyling, Vice President of Research and Scientific Affairs, will present on pathogen testing technology on May 10, while Kevin Giroux, Vice President of Sales and Marketing, will deliver opening remarks during the Keynote Session. The company will occupy booth #405 in the exhibit hall to discuss its Atlas Detection Assays and molecular diagnostic testing platform.PR NewswireRoka Bioscience to participate in the 40th Annual National Food Policy ConferenceRoka Bioscience announced that Dr. Erin Dreyling, Vice President of Research & Scientific Affairs, will participate as a panelist in two sessions at the 40th Annual National Food Policy Conference in Washington, DC on April 11-12, 2017. The sessions are titled "Big Data and the Future of Food Safety" and "Food Industry Disruptors." Dr. Dreyling stated she aims to raise awareness about the role of advanced pathogen detection technologies in improving food safety.PR NewswireRoka Bioscience to Present at the Sidoti & Company Spring 2017 ConventionRoka Bioscience announced that CEO Mary Duseau will present at the Sidoti & Company Spring 2017 Convention on March 29 at 9:50am ET in New York. The conference will take place at the New York Marriott Marquis. The presentation is a routine investor relations activity for the molecular diagnostics company focused on foodborne pathogen detection.PR NewswireRoka Bioscience to Present at the 29th Annual Roth ConferenceRoka Bioscience, a molecular diagnostics company focused on foodborne pathogen detection, announced that CEO Mary Duseau will present at the 29th Annual Roth Conference on March 14, 2017 at 8:00am PT in Dana Point, California. The conference is a major institutional investor event, providing the company an opportunity to address institutional investors and analysts. This is a routine investor relations announcement focused on conference participation.PR NewswireRoka Bioscience Reports Fourth Quarter and Full Year 2016 Financial ResultsRoka Bioscience reported Q4 2016 revenue of $1.9 million, a 27% increase from $1.5 million in Q4 2015, while full-year 2016 revenue grew 21% to $7.2 million from $6.0 million in 2015. Despite the revenue growth, the company reported a net loss applicable to common shareholders of $13.3 million for Q4 and $38.5 million for the full year, though the per-share loss narrowed from $21.18 to $17.42. The company's cash and marketable securities decreased to $24.8 million as of December 31, 2016, down from $32.3 million at the end of 2015, and it placed 53 instruments with customers under commercial agreements, up from 41.